MYC and cancer: Research suggests that SRSF1 is commonly upregulated in cancer and serves as a direct target of Myc (52) .Additionally, enrichment analyses of pathways such as T_CELL_RECEPTOR_SIGNALING_PATHWAY, SPLICEOSOME, and CELL_CYCLE highlight their significant involvement in regulating critical biological processes including cellular immune response, splicing mechanisms, and cell cycle dynamics.